Attention Deficit Hyperactivity Disorder
📧 Sign up to get email alerts when something new happens for Attention Deficit Hyperactivity Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-09-09FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE — Original Application (Granules Pharmaceuticals Inc.)
FDA approved the original application for Dexmethylphenidate hydrochloride from Granules Pharmaceuticals Inc., adding a generic option for t…
-
FDA approval · 2020-08-19FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries' methylphenidate hydrochloride generic under an original application (ANDA 205135).
-
FDA approval · 2020-08-04FDA Approved: CLONIDINE HYDROCHLORIDE — Supplemental Application (BluePoint Laboratories)
The FDA approved BluePoint Laboratories' supplemental application for clonidine hydrochloride (ANDA), granting a supplemental approval for t…
-
FDA approval · 2020-07-29FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Original Application (Dr.Reddys Laboratories Inc)
FDA approves the original ANDA for methylphenidate hydrochloride from Dr. Reddy's Laboratories, making a generic ADHD treatment available.
-
FDA approval · 2020-07-23FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Original Application (Solco Healthcare US,LLC)
FDA approved Solco Healthcare US, LLC's original application for methylphenidate hydrochloride, a generic medication indicated for ADHD and …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2020-06-04FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Original Application (QUAGEN PHARMACEUTICALS LLC)
FDA approved the Original Application for methylphenidate hydrochloride from Quagen Pharmaceuticals LLC, making a generic methylphenidate hy…
-
FDA approval · 2020-05-27FDA Approved: CLONIDINE HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for clonidine hydrochloride from Actavis Pharma, Inc. to bring a generic version of the antihype…
-
FDA approval · 2020-05-21FDA Approved: CLONIDINE HYDROCHLORIDE — Supplemental Application (Somerset Therapeutics, LLC)
FDA approved a supplemental application for clonidine hydrochloride from Somerset Therapeutics, LLC, under an ANDA, indicating approval of a…
-
FDA approval · 2020-05-21FDA Approved: GUANFACINE — Supplemental Application (Actavis Pharma, Inc.)
The FDA granted approval of a supplemental application for guanfacine from Actavis Pharma, enabling the generic version to be marketed. This…
-
FDA approval · 2020-05-21FDA Approved: GUANFACINE — Supplemental Application (Sun Pharmaceutical Industries, Inc)
FDA approved a supplemental application for guanfacine from Sun Pharmaceutical Industries (ANDA205689).
-
FDA approval · 2020-05-21FDA Approved: CLONIDINE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for clonidine hydrochloride by Lupin Pharmaceuticals, Inc., under the ANDA framework.
-
FDA approval · 2020-04-10FDA Approved: METHYLPHENIDATE HCL — Original Application (Patrin Pharma, Inc.)
FDA approved Patrin Pharma, Inc.'s original ANDA for methylphenidate hydrochloride (generic) for the treatment of attention-deficit/hyperact…
-
FDA approval · 2020-04-03FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Original Application (Oryza Pharmaceuticals Inc.)
FDA approved the generic combination product containing dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and …
-
FDA approval · 2020-03-30FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Original Application (Ascend Laboratories, LLC)
FDA approved an original ANDA for methylphenidate hydrochloride (generic) manufactured by Ascend Laboratories, LLC.
-
FDA approval · 2020-03-11FDA Approved: AMPHETAMINE SULFATE — Original Application (Solco Healthcare US, LLC)
FDA approves the original application for amphetamine sulfate (generic) to be marketed by Solco Healthcare US, LLC.
-
FDA approval · 2020-02-25FDA Approved: STRATTERA — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Strattera (atomoxetine hydrochloride) submitted by Eli Lilly and Company.
-
FDA approval · 2020-01-08FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for methylphenidate hydrochloride manufactured by Sun Pharmaceutical Industries, Inc. This actio…
-
FDA approval · 2019-12-27FDA Approved: INTUNIV — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for INTUNIV (guanfacine) by Takeda Pharmaceuticals America, Inc. The approval pertains to a modifica…
-
FDA approval · 2019-12-11FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE — Original Application (Elite Laboratories, Inc.)
The FDA approved Elite Laboratories' generic mixed amphetamine salts product under an original ANDA. The product contains four salt forms of…
-
FDA approval · 2019-11-29FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for dexmethylphenidate hydrochloride (Teva Pharmaceuticals USA, Inc.). The decision updates the appr…
-
FDA approval · 2019-11-29FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Dexmethylphenidate hydrochloride by Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2019-11-29FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for Dexmethylphenidate hydrochloride from Amneal Pharmaceuticals of New York LLC, supporting the gen…
-
FDA approval · 2019-11-29FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved Sun Pharmaceutical's supplemental application to market a generic dexmethylphenidate hydrochloride product for attention-de…
-
FDA approval · 2019-11-29FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Cranbury Pharmaceuticals, LLC)
FDA approved a supplemental application for dexmethylphenidate hydrochloride from Cranbury Pharmaceuticals, LLC.
-
FDA approval · 2019-11-29FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Par Health USA, LLC)
FDA approved a supplemental application for Dexmethylphenidate hydrochloride, a generic ADHD medication, submitted by Par Health USA, LLC.